Bicycle therapeutics to participate in upcoming investor conferences

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in the following investor conferences in november and december: jefferies london healthcare conference on friday, november 19, 2021; pre-recorded fireside chat available on demand at 3:00 a.m. et on thursday, novembe
BCYC Ratings Summary
BCYC Quant Ranking